Measles & Rubella Weekly Monitoring Report – Week 16: April 14 to April 20, 2024
Organization: Public Health Agency of Canada
Date published: 2024-04-30
Related Topics
Key points:
- In Canada, 6 new cases of measles and no new cases of rubella were reported in week 16, 2024.
- Currently, there are 45 activeFootnote 1 cases of measles in Canada.
- 65 cases of measles and 1 case of congenital rubella syndrome/infection have been reported in Canada in 2024. Please note, 1 previously reported measles case in Quebec has been discarded, following confirmatory laboratory testing.
- Canadians travelling outside of Canada are encouraged to consult the travel health notices for information on measles and rubella outbreaks occurring in other countries.
On this page
Epidemiological summary
During epidemiological week 16, 2024, 6 new cases of measles and no new cases of rubella were reported in CanadaFootnote 2. 5 cases were reported by the province of Quebec. All cases had rash onset in epidemiological week 16.
1 case was reported by the province of Ontario. The case was an unvaccinated child who had a recent travel to Saudi Arabia. Rash onset occurred in epidemiological week 16.
To date in 2024, 65 cases of measles and 1 case of congenital rubella syndrome/infection have been reported. The last case of rubella was reported in September 2023.
Figure 1 - Text description
Epidemiological Week of Rash Onset, 2024 | Number of confirmed measles cases reported | Number of confirmed rubella cases reported | Number of confirmed congenital rubella syndrome/infection cases reported |
---|---|---|---|
1 | 0 | 0 | 0 |
2 | 1 | 0 | 0 |
3 | 1 | 0 | 0 |
4 | 0 | 0 | 0 |
5 | 1 | 0 | 0 |
6 | 1 | 0 | 1 |
7 | 3 | 0 | 0 |
8 | 3 | 0 | 0 |
9 | 10 | 0 | 0 |
10 | 6 | 0 | 0 |
11 | 8 | 0 | 0 |
12 | 6 | 0 | 0 |
13 | 8 | 0 | 0 |
14 | 7 | 0 | 0 |
15 | 4 | 0 | 0 |
16 | 6 | 0 | 0 |
17 | 0 | 0 | 0 |
18 | 0 | 0 | 0 |
19 | 0 | 0 | 0 |
20 | 0 | 0 | 0 |
21 | 0 | 0 | 0 |
22 | 0 | 0 | 0 |
23 | 0 | 0 | 0 |
24 | 0 | 0 | 0 |
25 | 0 | 0 | 0 |
26 | 0 | 0 | 0 |
27 | 0 | 0 | 0 |
28 | 0 | 0 | 0 |
29 | 0 | 0 | 0 |
30 | 0 | 0 | 0 |
31 | 0 | 0 | 0 |
32 | 0 | 0 | 0 |
33 | 0 | 0 | 0 |
34 | 0 | 0 | 0 |
35 | 0 | 0 | 0 |
36 | 0 | 0 | 0 |
37 | 0 | 0 | 0 |
38 | 0 | 0 | 0 |
39 | 0 | 0 | 0 |
40 | 0 | 0 | 0 |
41 | 0 | 0 | 0 |
42 | 0 | 0 | 0 |
43 | 0 | 0 | 0 |
44 | 0 | 0 | 0 |
45 | 0 | 0 | 0 |
46 | 0 | 0 | 0 |
47 | 0 | 0 | 0 |
48 | 0 | 0 | 0 |
49 | 0 | 0 | 0 |
50 | 0 | 0 | 0 |
51 | 0 | 0 | 0 |
52 | 0 | 0 | 0 |
Cases (year-to-date) | 65 | 0 | 1 |
Geographic distribution
There are currently 45 activeFootnote * cases of measles in Canada.
Figure 2 - Text description
Health Region | Measles Active Cases |
---|---|
Eastern Regional Integrated Health Authority | 0 |
Central Regional Integrated Health Authority | 0 |
Western Regional Integrated Health Authority | 0 |
Labrador-Grenfell Regional Integrated Health Authority | 0 |
Prince Edward Island | 0 |
South Shore District Health Authority | 0 |
South West Nova District Health Authority | 0 |
Annapolis Valley District Health Authority | 0 |
Colchester East Hants Health Authority | 0 |
Cumberland Health Authority | 0 |
Pictou County Health Authority | 0 |
Guysborough Antigonish Strait Health Authority | 0 |
Cape Breton District Health Authority | 0 |
Capital District Health Authority | 0 |
Zone 1 (NB) | 0 |
Zone 2 (NB) | 0 |
Zone 3 (NB) | 0 |
Zone 4 (NB) | 0 |
Zone 5 (NB) | 0 |
Zone 6 (NB) | 0 |
Zone 7 (NB) | 0 |
Québec et Chaudières-Appalaches | 0 |
Centre-du-Québec | 6 |
Montréal et Laval | 14 |
Ouest-du-Québec | 4 |
Montérégie | 12 |
Nord-Est | 0 |
Ontario Central East | 1 |
Ontario Central West | 3 |
Ontario Eastern | 0 |
Ontario North East | 0 |
Ontario North West | 0 |
Ontario South West | 1 |
City of Toronto Health Unit | 4 |
Winnipeg Regional Health Authority | 0 |
Prairie Mountain Health | 0 |
Interlake-Eastern Regional Health Authority | 0 |
Northern Regional Health Authority | 0 |
Southern Health | 0 |
Saskatchewan South | 0 |
Saskatchewan Central | 0 |
Saskatchewan North | 0 |
South Zone | 0 |
Calgary Zone | 0 |
Central Zone | 0 |
Edmonton Zone | 0 |
North Zone | 0 |
British Columbia | 0 |
Yukon | 0 |
Northwest Territories | 0 |
Nunavut | 0 |
- Footnote *
-
Active measles cases are those in which the onset date of the case falls within 42 days of the end date of the epidemiological week of the report. The Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 7: Measles. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt07-measles.html. Page last reviewed: May 13, 2019.
Active rubella cases are those in which the onset date of the case falls within 46 days of the end date of the epidemiological week of the report. The Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 14: Rubella. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt14-rubella.html. Page last reviewed: May 18, 2018.
Laboratory summary
Measles
During epidemiological week 16, 2024, the measles genotype was identified for 4 cases that were reported in epidemiological weeks 14 and 15: 1 case was reported by the province of Quebec, and 3 cases were reported by the province of Ontario. The case reported in Quebec was an imported case with recent travel to Pakistan (genotype D8). All 3 cases reported in Ontario were imported cases: 2 cases acquired the infection in Pakistan prior to arriving in Canada, and 1 case had a recent travel to Pakistan (all genotype B3).
To date in 2024, 51 cases of measles have been genotyped; 42 were B3 and 9 were D8.
Figure 3 - Text description
Epi week | B3 | B3 - Harare | D4 | D8 | D8 – Taunton | D9 | H1 | Total |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
3 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
5 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
6 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
7 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
8 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 3 |
9 | 9 | 0 | 0 | 1 | 0 | 0 | 0 | 10 |
10 | 3 | 0 | 0 | 2 | 0 | 0 | 0 | 5 |
11 | 6 | 0 | 0 | 1 | 0 | 0 | 0 | 7 |
12 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
13 | 6 | 0 | 0 | 1 | 0 | 0 | 0 | 7 |
14 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
15 | 2 | 0 | 0 | 1 | 0 | 0 | 0 | 3 |
16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
21 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
22 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
27 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
28 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
32 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
34 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
35 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
37 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
39 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
43 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
48 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
49 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
51 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 42 | 0 | 0 | 9 | 0 | 0 | 0 | 51 |
- Footnote †
-
Epidemiological weeks for laboratory specimens submitted to the National Microbiology Laboratory are assigned and reported in accordance with WHO guidelines (WHO.WER.2012;9(87):73) with week 1 beginning on the first Monday of the year, which for 2024 is January 1. However, for the purposes of this report, the genotype data is presented in accordance with PAHO reporting weeks with week 1 of 2024 beginning on December 31, 2023.
For information regarding the interpretation and use of measles genotyping (including a discussion of genotypes and named strains), refer to Hiebert J and Severini A. Canada Communicable Disease Report. 2014; 40-12: 257- 260. URL : https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2014-40/rmtc-volume-40-12-12-juin-2014/rmtc-volume-40-12-12-juin-2014-1.html
The current global distribution of measles genotypes can be found on the WHO Measles Surveillance website. URL: https://www.who.int/teams/immunization-vaccines-and-biologicals/immunization-analysis-and-insights/surveillance/monitoring/provisional-monthly-measles-and-rubella-data
Footnotes
- Footnote 1
-
Active measles cases are those in which the onset date of the case falls within 42 days of the end date of the epidemiological week of the report. Active rubella cases are those in which the onset date of the case falls within 46 days of the end date of the epidemiological week of the report.
- Footnote 2
-
Only cases with rash onset up to the indicated end date are included in this report. Any additional cases will be described in future reports.
- Footnote 3
-
Epidemiological week of birth is used for congenital rubella syndrome/infection cases.
Page details
- Date modified: